Pharma’s customer engagement evolution: Is your data governance keeping pace?

Changing healthcare provider (HCP) and patient expectations have disrupted conventional customer engagement methods across the entire healthcare ecosystem. The traditional reach and frequency model that has been extremely successful for pharma companies is no longer adequate because the customer of today prefers a tailored experience delivered through their preferred channels.

Recent surveys have indicated that sales representatives get 3× the promotional responses when they engage HCPs via a combination of in-person and virtual channels, while leveraging personalized digital content drives 2.5× new patient starts. Now more than ever, pharma companies must adapt their customer engagement methods to focus on hyper-personalization. This approach delivers personalized content such as educational material, clinical trial results, etc. through omni-channel interactions (e.g., e-detailing, face to face, websites, etc.) that account for customer preferences, product archetypes, and environmental factors.

Click here to read the full Life Science Leader article